prenatal development according to the Organisation for Economic Co-operation and Development (OECD) 414 testing guideline. Theoretically, this would require substantial numbers of experimental animals (> 2500 animals/test/compound; OECD, 2001) and involve a considerable amount of resources, both monetary and in terms of capacity (van der Jagt et al., 2004;Rovida et al., 2011). Therefore, the use of a battery of in vitro alternative assays, such as the zebrafish embryotoxicity test (ZET; Sipes et al., 2011;Strähle et al., 2012) and/or the embryonic stem cell test (EST; Spielmann, 2009), to group PS into a limited number of categories and/or to facilitate read-across from PS for which in vivo PDT data are already available, may reduce the number of animals and resources needed to study PDT potencies of PS.The embryonic stem cell test (EST;Genschow et al., 2004), the whole embryo culture (WEC;Piersma et al., 2004), the limb bud micromass (Spielmann et al., 2004), and the zebrafish embryotoxicity test (ZET; OECD 2011a,b;Busquet et al., 2014), are the four in vitro alternative methods that have been validated for PDT testing.